6.45Open6.45Pre Close0 Volume5 Open Interest80.00Strike Price0.00Turnover39.13%IV-5.16%PremiumDec 20, 2024Expiry Date11.15Intrinsic Value100Multiplier23DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9207Delta0.0166Gamma7.79Leverage Ratio-0.0372Theta0.0452Rho7.17Eff Leverage0.0337Vega
AZZ Inc Stock Discussion
In reaction to earnings/guidance:
• $New Relic (NEWR.US)$ +3.8% (guidance), $American Airlines (AAL.US)$ +2% (guidance)
Other news:
• $DICE THERAPEUTICS, INC. (DICE.US)$ +66.5% (announces "positive" topline data from its Phase 1 clinical trial of DC-806 an oral small molecule antagonist of the pro-inflammatory cytokine IL-17)
• $Albireo Pharma (ALBO.US)$ +17.2% (reports positive topline data from Phase 3 Trial of Bylvay (odevix...
- $Consolidated Communications (CNSL.US)$ +14.6%: Searchlight affirms 34.6% active holding; to evaluate the possibility of a further investment in or full acquisition.
- $Voyager Therapeutics (VYGR.US)$ +12.2%: agrees to licensing option with $Novartis AG (NVS.US)$; Voyager receives $54 million upfront.
- $Aegon Ltd (AEG.US)$ +6%: provides update on Russian and Belarusian investments following invasion of Ukraine.
- $AZZ Inc (AZZ.US)$ +...
No comment yet